813 studies found for:    Open Studies | "Blood Coagulation Disorders"
Show Display Options
Rank Status Study
21 Recruiting Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa pegol
22 Recruiting Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B
Conditions: Congenital Bleeding Disorder;   Haemophilia B
Intervention: Drug: nonacog beta pegol
23 Recruiting Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
24 Recruiting Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
25 Not yet recruiting Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)
Conditions: Trauma;   Injury;   Bleeding;   Haemorrhage;   Coagulopathy
Interventions: Drug: Fibrinogen concentrate;   Drug: Placebo Comparator
26 Recruiting The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
Condition: Glanzmann Thrombasthenia
Intervention:
27 Recruiting Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers
Condition: Coagulation Defects
Interventions: Biological: Spray-dried S/D-treated Plasma;   Drug: Spray-dried S/D-treated plasma
28 Unknown  Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.
Condition: Blood Coagulation Disorder
Intervention: Device: Hemosense (PT/InR point of care device)
29 Not yet recruiting Post-Marketing Requirement to Evaluate the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation With Special Emphasis on Hyperfibrinolysis.
Conditions: Coagulopathy;   Endstage Liver Disease
Interventions: Biological: Octaplas™;   Biological: Plasma
30 Recruiting Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
Conditions: Hereditary Bleeding Disorder;   Thrombotic Disorder
Intervention:
31 Recruiting Point-of-Care Testing in Coagulopathic Patients Undergoing Cardiac Surgery - a Multicenter Study
Condition: Coagulopathy During Cardiac Surgery
Interventions: Device: Conventional laboratory testing (Central laboratory);   Device: POC testing
32 Unknown  RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma
Condition: Major Trauma
Interventions: Drug: Fibrinogen concentrate, Prothrombin complex concentrate and FXIII concentrate;   Drug: Fresh Frozen Plasma blood type 0, A, B and AB
33 Not yet recruiting Efficacy and Safety of Heparin-grafted Membrane for CRRT
Conditions: Acute Kidney Injury;   Hemorrhage;   Coagulopathy
Interventions: Device: oXiris as first filter;   Device: M150 as first filter
34 Not yet recruiting Open-label, Multicenter, Post-Marketing Requirement Study to Investigate Safety, Tolerability and Efficacy of octaplasLG in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors
Conditions: Liver or Cardiac Surgery;   Liver Dysfunction;   Coagulopathy
Intervention: Biological: octaplasLG
35 Not yet recruiting Thromboelastography During Surgery for Malignant Pleural Mesothelioma
Conditions: Coagulopathy;   Mesothelioma
Intervention: Procedure: Blood draw for TEG analysis
36 Recruiting Pharmacogenetics of Warfarin in Puerto Ricans.
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy
Intervention:
37 Not yet recruiting Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze
Conditions: Bleeding;   Coagulopathy
Intervention: Device: pad-gauze with tranexamic acid (Hemostopan™)
38 Recruiting Markers of Defective Membrane Remodelling in Scott-like Syndromes
Conditions: Unexplained Isolated Provoked Hemorrhages;   Familial Bleeding Disorder;   Scott Syndrome
Intervention: Other: Blood withdrawal
39 Recruiting Estradiol vs Lysteda in Treatment of Heavy Menstrual Bleeding
Condition: Menstrual Cycle and Uterine Bleeding Disorders
Interventions: Drug: Estradiol;   Drug: Lysteda
40 Recruiting A Gray Zone Approach of Rotational Thromboelastometry for Predicting Postoperative Bleeding in Cardiac Surgical Patients
Conditions: Other Functional Disturbances Following Cardiac Surgery;   Postoperative Hemorrhage;   Coagulation Defect; Bleeding
Intervention: Device: ROTEM

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years